Discordant effects of rasagiline doses in Parkinson disease

Nat Rev Neurol. 2010 Jul;6(7):1p following 410. doi: 10.1038/nrneurol.2010.2-c1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Dose-Response Relationship, Drug
  • Glyceraldehyde-3-Phosphate Dehydrogenases / antagonists & inhibitors
  • Humans
  • Indans / administration & dosage*
  • Indans / pharmacology
  • Indans / therapeutic use*
  • Neuroprotective Agents / administration & dosage*
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / drug therapy*

Substances

  • Indans
  • Neuroprotective Agents
  • rasagiline
  • Glyceraldehyde-3-Phosphate Dehydrogenases